{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T08:13:14Z","timestamp":1751443994811,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":122,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071618837"},{"type":"electronic","value":"9781071618844"}],"license":[{"start":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T00:00:00Z","timestamp":1639699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T00:00:00Z","timestamp":1639699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-1-0716-1884-4_7","type":"book-chapter","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T16:04:44Z","timestamp":1639670684000},"page":"149-175","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Vaccines Targeting Numerous Coronavirus Antigens, Ensuring Broader Global Population Coverage: Multi-epitope and Multi-patch Vaccines"],"prefix":"10.1007","author":[{"given":"Sukrit","family":"Srivastava","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spyros D.","family":"Chatziefthymiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Kolbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,12,17]]},"reference":[{"key":"7_CR1","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.7150\/ijbs.45472","volume":"16","author":"Z-W Ye","year":"2020","unstructured":"Ye Z-W, Yuan S, Yuen K-S et al (2020) Zoonotic origins of human coronaviruses. Int J Biol Sci 16:1686\u20131697. https:\/\/doi.org\/10.7150\/ijbs.45472","journal-title":"Int J Biol Sci"},{"key":"7_CR2","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1056\/nejmoa030781","volume":"348","author":"TG Ksiazek","year":"2003","unstructured":"Ksiazek TG, Erdman D, Goldsmith CS et al (2003) A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 348:1953\u20131966. https:\/\/doi.org\/10.1056\/nejmoa030781","journal-title":"N Engl J Med"},{"key":"7_CR3","doi-asserted-by":"publisher","first-page":"18825","DOI":"10.1038\/srep18825","volume":"6","author":"J Kim II","year":"2016","unstructured":"Kim J II, Kim YJ, Lemey P et al (2016) The recent ancestry of Middle East respiratory syndrome coronavirus in Korea has been shaped by recombination. Sci Rep 6:18825. https:\/\/doi.org\/10.1038\/srep18825","journal-title":"Sci Rep"},{"key":"7_CR4","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2020.2648","volume":"323","author":"Z Wu","year":"2020","unstructured":"Wu Z, McGoogan JM (2020) Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA 323:1239\u20131242. https:\/\/doi.org\/10.1001\/jama.2020.2648","journal-title":"JAMA"},{"key":"7_CR5","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X et al (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395:507\u2013513. https:\/\/doi.org\/10.1016\/S0140-6736(20)30211-7","journal-title":"Lancet"},{"key":"7_CR6","first-page":"336","volume":"15","author":"WQ He","year":"2003","unstructured":"He WQ, Chen SB, Liu XQ et al (2003) Death risk factors of severe acute respiratory syndrome with acute respiratory distress syndrome. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 15:336\u2013337","journal-title":"Zhongguo Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"7_CR7","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/S0140-6736(03)14630-2","volume":"362","author":"NS Zhong","year":"2003","unstructured":"Zhong NS, Zheng BJ, Li YM et al (2003) Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People\u2019s Republic of China, in February, 2003. Lancet 362:1353\u20131358. https:\/\/doi.org\/10.1016\/S0140-6736(03)14630-2","journal-title":"Lancet"},{"key":"7_CR8","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/S1526-0542(03)00088-5","volume":"4","author":"TF Leung","year":"2003","unstructured":"Leung TF, Wong GWK, Hon KLE, Fok TF (2003) Severe acute respiratory syndrome (SARS) in children: epidemiology, presentation and management. Paediatr Respir Rev 4:334\u2013339. https:\/\/doi.org\/10.1016\/S1526-0542(03)00088-5","journal-title":"Paediatr Respir Rev"},{"key":"7_CR9","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/S0140-6736(13)61887-5","volume":"382","author":"M Cotten","year":"2013","unstructured":"Cotten M, Watson SJ, Kellam P et al (2013) Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study. Lancet 382:1993\u20132002. https:\/\/doi.org\/10.1016\/S0140-6736(13)61887-5","journal-title":"Lancet"},{"key":"7_CR10","doi-asserted-by":"publisher","DOI":"10.4178\/epih\/e2015033","volume":"37","author":"M Ki","year":"2015","unstructured":"Ki M (2015) 2015 MERS outbreak in Korea: hospital-to-hospital transmission. Epidemiol Health 37:e2015033. https:\/\/doi.org\/10.4178\/epih\/e2015033","journal-title":"Epidemiol Health"},{"key":"7_CR11","unstructured":"WHO (n.d.) Coronavirus disease 2019 (COVID-19). Situation report. WHO, Geneva"},{"key":"7_CR12","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang XL, Wang XG et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579:270\u2013273. https:\/\/doi.org\/10.1038\/s41586-020-2012-7","journal-title":"Nature"},{"key":"7_CR13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","volume":"395","author":"R Lu","year":"2020","unstructured":"Lu R, Zhao X, Li J et al (2020) Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395:565\u2013574. https:\/\/doi.org\/10.1016\/S0140-6736(20)30251-8","journal-title":"Lancet"},{"key":"7_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s41256-020-00135-6","volume":"5","author":"H Zhu","year":"2020","unstructured":"Zhu H, Wei L, Niu P (2020) The novel coronavirus outbreak in Wuhan, China. Glob Heal Res Policy 5:6. https:\/\/doi.org\/10.1186\/s41256-020-00135-6","journal-title":"Glob Heal Res Policy"},{"key":"7_CR15","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41392-020-00352-y","volume":"5","author":"Y Dong","year":"2020","unstructured":"Dong Y, Dai T, Wei Y et al (2020) A systematic review of SARS-CoV-2 vaccine candidates. Signal Transduct Target Ther 5:237. https:\/\/doi.org\/10.1038\/s41392-020-00352-y","journal-title":"Signal Transduct Target Ther"},{"key":"7_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","volume":"582","author":"Z Jin","year":"2020","unstructured":"Jin Z, Du X, Xu Y et al (2020) Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature 582:289\u2013293. https:\/\/doi.org\/10.1038\/s41586-020-2223-y","journal-title":"Nature"},{"key":"7_CR17","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.abb2507","volume":"367","author":"D Wrapp","year":"2020","unstructured":"Wrapp D, Wang N, Corbett KS et al (2020) Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science (80- ) 367:1260\u20131263. https:\/\/doi.org\/10.1126\/science.abb2507","journal-title":"Science (80- )"},{"key":"7_CR18","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1126\/science.abc1560","volume":"368","author":"W Yin","year":"2020","unstructured":"Yin W, Mao C, Luan X et al (2020) Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir. Science (80- ) 368:1499\u20131504. https:\/\/doi.org\/10.1126\/science.abc1560","journal-title":"Science (80- )"},{"key":"7_CR19","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","volume":"583","author":"DE Gordon","year":"2020","unstructured":"Gordon DE, Jang GM, Bouhaddou M et al (2020) A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 583:459\u2013468. https:\/\/doi.org\/10.1038\/s41586-020-2286-9","journal-title":"Nature"},{"key":"7_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.4103\/ijp.IJP_115_20","volume":"52","author":"M Prajapat","year":"2020","unstructured":"Prajapat M, Sarma P, Shekhar N et al (2020) Drug for corona virus: a systematic review. Indian J Pharmacol 52:56. https:\/\/doi.org\/10.4103\/ijp.IJP_115_20","journal-title":"Indian J Pharmacol"},{"key":"7_CR21","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1126\/science.1116480","volume":"309","author":"F Li","year":"2005","unstructured":"Li F, Li W, Farzan M, Harrison SC (2005) Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 309:1864\u20131868. https:\/\/doi.org\/10.1126\/science.1116480","journal-title":"Science"},{"key":"7_CR22","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3389\/fimmu.2016.00481","volume":"7","author":"CE Hughes","year":"2016","unstructured":"Hughes CE, Benson RA, Bedaj M, Maffia P (2016) Antigen-presenting cells and antigen presentation in tertiary lymphoid organs. Front Immunol 7:481. https:\/\/doi.org\/10.3389\/fimmu.2016.00481","journal-title":"Front Immunol"},{"key":"7_CR23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/s0952-7915(02)00010-9","volume":"15","author":"AN Antoniou","year":"2003","unstructured":"Antoniou AN, Powis SJ, Elliott T (2003) Assembly and export of MHC class I peptide ligands. Curr Opin Immunol 15:75\u201381. https:\/\/doi.org\/10.1016\/s0952-7915(02)00010-9","journal-title":"Curr Opin Immunol"},{"key":"7_CR24","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1128\/CMR.00005-06","volume":"19","author":"L Gillim-Ross","year":"2006","unstructured":"Gillim-Ross L, Subbarao K (2006) Emerging respiratory viruses: challenges and vaccine strategies. Clin Microbiol Rev 19:614\u2013636. https:\/\/doi.org\/10.1128\/CMR.00005-06","journal-title":"Clin Microbiol Rev"},{"key":"7_CR25","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12929-020-00695-2","volume":"27","author":"Y-D Li","year":"2020","unstructured":"Li Y-D, Chi W-Y, Su J-H et al (2020) Coronavirus vaccine development: from SARS and MERS to COVID-19. J Biomed Sci 27:104. https:\/\/doi.org\/10.1186\/s12929-020-00695-2","journal-title":"J Biomed Sci"},{"key":"7_CR26","unstructured":"WHO (n.d.) List of candidate vaccines developed against SARS-CoV. WHO, Geneva"},{"key":"7_CR27","unstructured":"WHO (n.d.) List of candidate vaccines developed against MERS-CoV. WHO, Geneva"},{"key":"7_CR28","unstructured":"WHO (n.d.) Draft landscape and tracker of COVID-19 candidate vaccines. WHO, Geneva"},{"key":"7_CR29","unstructured":"CDC (n.d.) COVID-19 vaccine Emergency Use Authorization (EUA) fact sheets for recipients and caregivers. CDC, Atlanta, GA. https:\/\/www.cdc.gov\/vaccines\/covid-19\/eua\/index.html"},{"key":"7_CR30","unstructured":"FDA (n.d.) Fact sheet for recipients and caregivers, Emergency Use Authorization (EUA) of the pfizer-biontech covid-19 vaccine to prevent coronavirus disease 2019 (Covid-19), in individuals 16 years of age and older. FDA, Silver Spring, MD. https:\/\/www.fda.gov\/media\/144414"},{"key":"7_CR31","unstructured":"FDA (n.d.) Fact sheet for recipients and caregivers, Emergency Use Authorization (EUA) of the moderna covid-19 vaccine to prevent coronavirus disease 2019 (Covid-19), in individuals 18 years of age and older. FDA, Silver Spring, MD. https:\/\/www.modernatx.com\/covid19vaccine-eua\/eua-fact-sheet-recipients.pdf"},{"key":"7_CR32","unstructured":"CDC (n.d.) COVID-19 AstraZeneca vaccine EUA fact sheet for recipients. CDC, Atlanta, GA. https:\/\/www.cdc.gov\/vaccines\/covid-19\/eua\/astrazeneca.html"},{"key":"7_CR33","unstructured":"FDA (n.d.) Fact sheet for recipients and caregivers, Emergency Use Authorization (EUA) of the janssen covid-19 vaccine to prevent coronavirus disease 2019 (Covid-19), in individuals 18 years of age and older. FDA, Silver Spring, MD"},{"key":"7_CR34","unstructured":"WHO (n.d.) Lists two additional COVID-19 vaccines for emergency use and COVAX roll-out. WHO, Geneva"},{"key":"7_CR35","unstructured":"WHO (n.d.) Recommendation AstraZeneca\/SKBio - COVID-19 vaccine (ChAdOx1-S [recombinant]). WHO, Geneva. https:\/\/extranet.who.int\/pqweb\/vaccines\/covid-19-vaccine-chadox1-s-recombinant"},{"key":"7_CR36","unstructured":"WHO (n.d.) Recommendation Serum Institute of India Pvt Ltd - COVID-19 vaccine (ChAdOx1-S [recombinant]) - COVISHIELD. WHO, Geneva. https:\/\/extranet.who.int\/pqweb\/vaccines\/covid-19-vaccine-chadox1-s-recombinant-covishield"},{"key":"7_CR37","unstructured":"WHO (n.d.) Issues its first emergency use validation for a COVID-19 vaccine and emphasizes need for equitable global access. WHO, Geneva. https:\/\/www.who.int\/news\/item\/31-12-2020-who-issues-its-first-emergency-use-validation-for-a-covid-19-vaccine-and-emphasizes-need-for-equitable-global-access"},{"key":"7_CR38","doi-asserted-by":"publisher","first-page":"4345","DOI":"10.1080\/07391102.2018.1548977","volume":"37","author":"S Srivastava","year":"2019","unstructured":"Srivastava S, Kamthania M, Kumar Pandey R et al (2019) Design of novel multi-epitope vaccines against severe acute respiratory syndrome validated through multistage molecular interaction and dynamics. J Biomol Struct Dyn 37:4345\u20134360. https:\/\/doi.org\/10.1080\/07391102.2018.1548977","journal-title":"J Biomol Struct Dyn"},{"key":"7_CR39","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.2147\/IDR.S175114","volume":"11","author":"S Srivastava","year":"2018","unstructured":"Srivastava S, Kamthania M, Singh S et al (2018) Structural basis of development of multi-epitope vaccine against Middle East respiratory syndrome using in silico approach. Infect Drug Resist 11:2377\u20132391. https:\/\/doi.org\/10.2147\/IDR.S175114","journal-title":"Infect Drug Resist"},{"key":"7_CR40","doi-asserted-by":"publisher","DOI":"10.2196\/19371","volume":"1","author":"S Srivastava","year":"2020","unstructured":"Srivastava S, Verma S, Kamthania M et al (2020) Structural basis for designing multiepitope vaccines against COVID-19 infection: in silico vaccine design and validation. JMIR Bioinforma Biotechnol 1:e19371. https:\/\/doi.org\/10.2196\/19371","journal-title":"JMIR Bioinforma Biotechnol"},{"key":"7_CR41","volume-title":"A novel method for designing multi-patch vaccine and diagnostic kit. Patent No. 202011037585","author":"S Srivastava","year":"2020","unstructured":"Srivastava S (2020) A novel method for designing multi-patch vaccine and diagnostic kit. Patent No. 202011037585"},{"key":"7_CR42","volume-title":"A novel multi-patch vaccine design to combat SARS-CoV-2 and a method to prepare thereof. Patent No. 202011037939","author":"S Srivastava","year":"2020","unstructured":"Srivastava S (2020) A novel multi-patch vaccine design to combat SARS-CoV-2 and a method to prepare thereof. Patent No. 202011037939"},{"key":"7_CR43","doi-asserted-by":"publisher","unstructured":"Srivastava S, Verma S, Kamthania M et al (2020) Computationally validated SARS-CoV-2 CTL and HTL multi-patch vaccines, designed by reverse epitomics approach, show potential to cover large ethnically distributed human population worldwide. J Biomol Struct Dyn:1\u201320. https:\/\/doi.org\/10.1080\/07391102.2020.1838329","DOI":"10.1080\/07391102.2020.1838329"},{"key":"7_CR44","volume-title":"Pink book webinar series","author":"J Wolicki","year":"2019","unstructured":"Wolicki J (2019) Principles of vaccination. In: Pink book webinar series"},{"key":"7_CR45","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.1128\/jvi.78.8.3863-3871.2004","volume":"78","author":"BJ Haijema","year":"2004","unstructured":"Haijema BJ, Volders H, Rottier PJM (2004) Live, attenuated coronavirus vaccines through the directed deletion of group-specific genes provide protection against feline infectious peritonitis. J Virol 78:3863\u20133871. https:\/\/doi.org\/10.1128\/jvi.78.8.3863-3871.2004","journal-title":"J Virol"},{"key":"7_CR46","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1080\/21645515.2020.1740560","volume":"16","author":"W-H Chen","year":"2020","unstructured":"Chen W-H, Hotez PJ, Bottazzi ME (2020) Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19. Hum Vaccin Immunother 16:1239\u20131242. https:\/\/doi.org\/10.1080\/21645515.2020.1740560","journal-title":"Hum Vaccin Immunother"},{"key":"7_CR47","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1056\/NEJMoa2026920","volume":"383","author":"C Keech","year":"2020","unstructured":"Keech C, Albert G, Cho I et al (2020) Phase 1-2 trial of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine. N Engl J Med 383:2320\u20132332. https:\/\/doi.org\/10.1056\/NEJMoa2026920","journal-title":"N Engl J Med"},{"key":"7_CR48","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1126\/science.abc6284","volume":"369","author":"J Yu","year":"2020","unstructured":"Yu J, Tostanoski LH, Peter L et al (2020) DNA vaccine protection against SARS-CoV-2 in rhesus macaques. Science 369:806\u2013811. https:\/\/doi.org\/10.1126\/science.abc6284","journal-title":"Science"},{"key":"7_CR49","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1038\/s41467-020-16505-0","volume":"11","author":"TRF Smith","year":"2020","unstructured":"Smith TRF, Patel A, Ramos S et al (2020) Immunogenicity of a DNA vaccine candidate for COVID-19. Nat Commun 11:2601. https:\/\/doi.org\/10.1038\/s41467-020-16505-0","journal-title":"Nat Commun"},{"key":"7_CR50","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","volume":"586","author":"KS Corbett","year":"2020","unstructured":"Corbett KS, Edwards DK, Leist SR et al (2020) SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness. Nature 586:567\u2013571. https:\/\/doi.org\/10.1038\/s41586-020-2622-0","journal-title":"Nature"},{"key":"7_CR51","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.cell.2020.07.024","volume":"182","author":"N-N Zhang","year":"2020","unstructured":"Zhang N-N, Li X-F, Deng Y-Q et al (2020) A Thermostable mRNA Vaccine against COVID-19. Cell 182:1271\u20131283.e16. https:\/\/doi.org\/10.1016\/j.cell.2020.07.024","journal-title":"Cell"},{"key":"7_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/2683286","volume":"2020","author":"MI Abdelmageed","year":"2020","unstructured":"Abdelmageed MI, Abdelmoneim AH, Mustafa MI et al (2020) Design of a multiepitope-based peptide vaccine against the E protein of human COVID-19: an immunoinformatics approach. Biomed Res Int 2020:1\u201312. https:\/\/doi.org\/10.1155\/2020\/2683286","journal-title":"Biomed Res Int"},{"key":"7_CR53","doi-asserted-by":"publisher","first-page":"100036","DOI":"10.1016\/j.xcrm.2020.100036","volume":"1","author":"M Yarmarkovich","year":"2020","unstructured":"Yarmarkovich M, Warrington JM, Farrel A, Maris JM (2020) Identification of SARS-CoV-2 vaccine epitopes predicted to induce long-term population-scale immunity. Cell Rep Med 1:100036. https:\/\/doi.org\/10.1016\/j.xcrm.2020.100036","journal-title":"Cell Rep Med"},{"key":"7_CR54","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.chom.2020.03.002","volume":"27","author":"A Grifoni","year":"2020","unstructured":"Grifoni A, Sidney J, Zhang Y et al (2020) A sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2. Cell Host Microbe 27:671\u2013680.e2. https:\/\/doi.org\/10.1016\/j.chom.2020.03.002","journal-title":"Cell Host Microbe"},{"key":"7_CR55","doi-asserted-by":"publisher","unstructured":"Grifoni A, Sidney J, Zhang Y et al (2020) Candidate targets for immune responses to 2019-novel coronavirus (nCoV): sequence homology- and bioinformatic-based predictions. SSRN:3541361. https:\/\/doi.org\/10.2139\/ssrn.3541361","DOI":"10.2139\/ssrn.3541361"},{"key":"7_CR56","doi-asserted-by":"publisher","first-page":"2683286","DOI":"10.1155\/2020\/2683286","volume":"2020","author":"MI Abdelmageed","year":"2020","unstructured":"Abdelmageed MI, Abdelmoneim AH, Mustafa MI et al (2020) Design of a multiepitope-based peptide vaccine against the E protein of human COVID-19: an immunoinformatics approach. Biomed Res Int 2020:2683286. https:\/\/doi.org\/10.1155\/2020\/2683286","journal-title":"Biomed Res Int"},{"key":"7_CR57","doi-asserted-by":"publisher","first-page":"16219","DOI":"10.1038\/s41598-020-73371-y","volume":"10","author":"A Singh","year":"2020","unstructured":"Singh A, Thakur M, Sharma LK, Chandra K (2020) Designing a multi-epitope peptide based vaccine against SARS-CoV-2. Sci Rep 10:16219. https:\/\/doi.org\/10.1038\/s41598-020-73371-y","journal-title":"Sci Rep"},{"key":"7_CR58","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.cels.2020.06.009","volume":"11","author":"G Liu","year":"2020","unstructured":"Liu G, Carter B, Bricken T et al (2020) Computationally optimized SARS-CoV-2 MHC class I and II vaccine formulations predicted to target human haplotype distributions. Cell Syst 11:131\u2013144.e6. https:\/\/doi.org\/10.1016\/j.cels.2020.06.009","journal-title":"Cell Syst"},{"key":"7_CR59","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/jmv.25736","volume":"92","author":"M Bhattacharya","year":"2020","unstructured":"Bhattacharya M, Sharma AR, Patra P et al (2020) Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): immunoinformatics approach. J Med Virol 92:618\u2013631. https:\/\/doi.org\/10.1002\/jmv.25736","journal-title":"J Med Virol"},{"key":"7_CR60","doi-asserted-by":"crossref","unstructured":"Fast E, Altman RB, Chen B (2020) Potential T-cell and B-cell epitopes of 2019-nCoV. BioRxiv:955484","DOI":"10.1101\/2020.02.19.955484"},{"key":"7_CR61","doi-asserted-by":"crossref","unstructured":"Gupta E, Mishra RK, Niraj RRK (2020) Identification of potential vaccine candidates against SARS-CoV-2, a step forward to fight novel coronavirus 2019-nCoV: a reverse vaccinology approach. BioRxiv:039198","DOI":"10.1101\/2020.04.13.039198"},{"key":"7_CR62","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1021\/acsinfecdis.6b00006","volume":"2","author":"Q Wang","year":"2016","unstructured":"Wang Q, Zhang L, Kuwahara K et al (2016) Immunodominant SARS coronavirus epitopes in humans elicited both enhancing and neutralizing effects on infection in non-human primates. ACS Infect Dis 2:361\u2013376. https:\/\/doi.org\/10.1021\/acsinfecdis.6b00006","journal-title":"ACS Infect Dis"},{"key":"7_CR63","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0928-8244(03)00106-8","volume":"38","author":"LA Duits","year":"2003","unstructured":"Duits LA, Nibbering PH, van Strijen E et al (2003) Rhinovirus increases human beta-defensin-2 and -3 mRNA expression in cultured bronchial epithelial cells. FEMS Immunol Med Microbiol 38:59\u201364. https:\/\/doi.org\/10.1016\/S0928-8244(03)00106-8","journal-title":"FEMS Immunol Med Microbiol"},{"key":"7_CR64","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/s1471-4906(02)02246-9","volume":"23","author":"D Yang","year":"2002","unstructured":"Yang D, Biragyn A, Kwak LW, Oppenheim JJ (2002) Mammalian defensins in immunity: more than just microbicidal. Trends Immunol 23:291\u2013296. https:\/\/doi.org\/10.1016\/s1471-4906(02)02246-9","journal-title":"Trends Immunol"},{"key":"7_CR65","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2217\/fmb.09.104","volume":"5","author":"KG Kohlgraf","year":"2010","unstructured":"Kohlgraf KG, Pingel LC, Dietrich DE, Brogden KA (2010) Defensins as anti-inflammatory compounds and mucosal adjuvants. Future Microbiol 5:99\u2013113. https:\/\/doi.org\/10.2217\/fmb.09.104","journal-title":"Future Microbiol"},{"key":"7_CR66","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1016\/j.vaccine.2005.01.098","volume":"23","author":"AJ MacDonald","year":"2005","unstructured":"MacDonald AJ, Cao L, He Y et al (2005) rOv-ASP-1, a recombinant secreted protein of the helminth Onchocercavolvulus, is a potent adjuvant for inducing antibodies to ovalbumin, HIV-1 polypeptide and SARS-CoV peptide antigens. Vaccines 23:3446\u20133452. https:\/\/doi.org\/10.1016\/j.vaccine.2005.01.098","journal-title":"Vaccines"},{"key":"7_CR67","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1016\/j.vaccine.2015.02.053","volume":"33","author":"J Guo","year":"2015","unstructured":"Guo J, Yang Y, Xiao W et al (2015) A truncated fragment of Ov-ASP-1 consisting of the core pathogenesis-related-1 (PR-1) domain maintains adjuvanticity as the full-length protein. Vaccines 33:1974\u20131980. https:\/\/doi.org\/10.1016\/j.vaccine.2015.02.053","journal-title":"Vaccines"},{"key":"7_CR68","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.4049\/jimmunol.0800531","volume":"182","author":"Y He","year":"2009","unstructured":"He Y, Barker SJ, MacDonald AJ et al (2009) Recombinant Ov-ASP-1, a Th1-biased protein adjuvant derived from the helminth Onchocerca volvulus, can directly bind and activate antigen-presenting cells. J Immunol 182:4005\u20134016. https:\/\/doi.org\/10.4049\/jimmunol.0800531","journal-title":"J Immunol"},{"key":"7_CR69","doi-asserted-by":"publisher","first-page":"6652","DOI":"10.1128\/jvi.76.13.6652-6659.2002","volume":"76","author":"S Sasaki","year":"2002","unstructured":"Sasaki S, Amara RR, Yeow W-S et al (2002) Regulation of DNA-raised immune responses by cotransfected interferon regulatory factors. J Virol 76:6652\u20136659. https:\/\/doi.org\/10.1128\/jvi.76.13.6652-6659.2002","journal-title":"J Virol"},{"key":"7_CR70","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.vetimm.2010.04.008","volume":"137","author":"C Wan","year":"2010","unstructured":"Wan C, Yi L, Yang Z et al (2010) The Toll-like receptor adaptor molecule TRIF enhances DNA vaccination against classical swine fever. Vet Immunol Immunopathol 137:47\u201353. https:\/\/doi.org\/10.1016\/j.vetimm.2010.04.008","journal-title":"Vet Immunol Immunopathol"},{"key":"7_CR71","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3390\/vaccines8020153","volume":"8","author":"J Zhang","year":"2020","unstructured":"Zhang J, Zeng H, Gu J et al (2020) Progress and prospects on vaccine development against SARS-CoV-2. Vaccines 8:153. https:\/\/doi.org\/10.3390\/vaccines8020153","journal-title":"Vaccines"},{"key":"7_CR72","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1128\/JVI.02980-14","volume":"89","author":"Y Honda-Okubo","year":"2015","unstructured":"Honda-Okubo Y, Barnard D, Ong CH et al (2015) Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology. J Virol 89:2995\u20133007. https:\/\/doi.org\/10.1128\/JVI.02980-14","journal-title":"J Virol"},{"key":"7_CR73","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jbiotec.2003.09.009","volume":"107","author":"W Hu","year":"2004","unstructured":"Hu W, Li F, Yang X et al (2004) A flexible peptide linker enhances the immunoreactivity of two copies HBsAg preS1 (21-47) fusion protein. J Biotechnol 107:83\u201390. https:\/\/doi.org\/10.1016\/j.jbiotec.2003.09.009","journal-title":"J Biotechnol"},{"key":"7_CR74","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.addr.2012.09.039","volume":"65","author":"X Chen","year":"2013","unstructured":"Chen X, Zaro JL, Shen W-C (2013) Fusion protein linkers: property, design and functionality. Adv Drug Deliv Rev 65:1357\u20131369. https:\/\/doi.org\/10.1016\/j.addr.2012.09.039","journal-title":"Adv Drug Deliv Rev"},{"key":"7_CR75","doi-asserted-by":"publisher","first-page":"583","DOI":"10.2307\/4450982","volume":"62","author":"DG Gerbig Jr","year":"2000","unstructured":"Gerbig DG Jr, Fenk CJ, Goodhart AS (2000) The dot blot ELISA: a rapid & simple experiment to demonstrate antibody-antigen interactions. Am Biol Teach 62:583\u2013587. https:\/\/doi.org\/10.2307\/4450982","journal-title":"Am Biol Teach"},{"key":"7_CR76","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1177\/29.6.7252134","volume":"29","author":"JC Adams","year":"1981","unstructured":"Adams JC (1981) Heavy metal intensification of DAB-based HRP reaction product. J Histochem Cytochem 29:775. https:\/\/doi.org\/10.1177\/29.6.7252134","journal-title":"J Histochem Cytochem"},{"key":"7_CR77","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1177\/30.10.6182185","volume":"30","author":"SM Hsu","year":"1982","unstructured":"Hsu SM, Soban E (1982) Color modification of diaminobenzidine (DAB) precipitation by metallic ions and its application for double immunohistochemistry. J Histochem Cytochem 30:1079\u20131082. https:\/\/doi.org\/10.1177\/30.10.6182185","journal-title":"J Histochem Cytochem"},{"key":"7_CR78","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ab.2018.08.012","volume":"559","author":"E Heyduk","year":"2018","unstructured":"Heyduk E, Hickey R, Pozzi N, Heyduk T (2018) Peptide ligand-based ELISA reagents for antibody detection. Anal Biochem 559:55\u201361. https:\/\/doi.org\/10.1016\/j.ab.2018.08.012","journal-title":"Anal Biochem"},{"key":"7_CR79","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/978-1-4939-3037-1_17","volume":"1352","author":"J Pozsgay","year":"2016","unstructured":"Pozsgay J, Szarka E, Huber K et al (2016) Synthetic peptide-based ELISA and ELISpot assay for identifying autoantibody epitopes. Methods Mol Biol 1352:223\u2013233. https:\/\/doi.org\/10.1007\/978-1-4939-3037-1_17","journal-title":"Methods Mol Biol"},{"key":"7_CR80","first-page":"1","volume-title":"Affinity chromatography","author":"ACA Roque","year":"2008","unstructured":"Roque ACA, Lowe CR (2008) Affinity chromatography. In: Affinity chromatography. Humana Press, Totowa, NJ, pp 1\u201323"},{"key":"7_CR81","doi-asserted-by":"publisher","first-page":"Unit 5.5","DOI":"10.1002\/0471143030.cb0505s06","volume":"Chapter 5","author":"GB Irvine","year":"2001","unstructured":"Irvine GB (2001) Determination of molecular size by size-exclusion chromatography (gel filtration). Curr Protoc Cell Biol Chapter 5:Unit 5.5. https:\/\/doi.org\/10.1002\/0471143030.cb0505s06","journal-title":"Curr Protoc Cell Biol"},{"key":"7_CR82","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00018-005-4528-2","volume":"62","author":"S Tenzer","year":"2005","unstructured":"Tenzer S, Peters B, Bulik S et al (2005) Modeling the MHC class I pathway by combining predictions of proteasomal cleavage, TAP transport and MHC class I binding. Cell Mol Life Sci 62:1025\u20131037. https:\/\/doi.org\/10.1007\/s00018-005-4528-2","journal-title":"Cell Mol Life Sci"},{"key":"7_CR83","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.4049\/jimmunol.171.4.1741","volume":"171","author":"B Peters","year":"2003","unstructured":"Peters B, Bulik S, Tampe R et al (2003) Identifying MHC class I epitopes by predicting the TAP transport efficiency of epitope precursors. J Immunol 171:1741\u20131749. https:\/\/doi.org\/10.4049\/jimmunol.171.4.1741","journal-title":"J Immunol"},{"key":"7_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00251-008-0341-z","volume":"61","author":"I Hoof","year":"2009","unstructured":"Hoof I, Peters B, Sidney J et al (2009) NetMHCpan, a method for MHC class I binding prediction beyond humans. Immunogenetics 61:1\u201313. https:\/\/doi.org\/10.1007\/s00251-008-0341-z","journal-title":"Immunogenetics"},{"key":"7_CR85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1003266","volume":"9","author":"JJA Calis","year":"2013","unstructured":"Calis JJA, Maybeno M, Greenbaum JA et al (2013) Properties of MHC class I presented peptides that enhance immunogenicity. PLoS Comput Biol 9:e1003266. https:\/\/doi.org\/10.1371\/journal.pcbi.1003266","journal-title":"PLoS Comput Biol"},{"key":"7_CR86","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1186\/1471-2105-11-568","volume":"11","author":"P Wang","year":"2010","unstructured":"Wang P, Sidney J, Kim Y et al (2010) Peptide binding predictions for HLA DR, DP and DQ molecules. BMC Bioinformatics 11:568. https:\/\/doi.org\/10.1186\/1471-2105-11-568","journal-title":"BMC Bioinformatics"},{"key":"7_CR87","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1745-7580-4-2","volume":"4","author":"J Sidney","year":"2008","unstructured":"Sidney J, Assarsson E, Moore C et al (2008) Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries. Immunome Res 4:2. https:\/\/doi.org\/10.1186\/1745-7580-4-2","journal-title":"Immunome Res"},{"key":"7_CR88","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/1471-2105-8-238","volume":"8","author":"M Nielsen","year":"2007","unstructured":"Nielsen M, Lundegaard C, Lund O (2007) Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method. BMC Bioinformatics 8:238. https:\/\/doi.org\/10.1186\/1471-2105-8-238","journal-title":"BMC Bioinformatics"},{"key":"7_CR89","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/9858","volume":"17","author":"T Sturniolo","year":"1999","unstructured":"Sturniolo T, Bono E, Ding J et al (1999) Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat Biotechnol 17:555\u2013561. https:\/\/doi.org\/10.1038\/9858","journal-title":"Nat Biotechnol"},{"key":"7_CR90","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1745-7580-2-2","volume":"2","author":"JEP Larsen","year":"2006","unstructured":"Larsen JEP, Lund O, Nielsen M (2006) Improved method for predicting linear B-cell epitopes. Immunome Res 2:2. https:\/\/doi.org\/10.1186\/1745-7580-2-2","journal-title":"Immunome Res"},{"key":"7_CR91","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/9780470122921.ch2","volume":"47","author":"PY Chou","year":"1978","unstructured":"Chou PY, Fasman GD (1978) Prediction of the secondary structure of proteins from their amino acid sequence. Adv Enzymol Relat Areas Mol Biol 47:45\u2013148. https:\/\/doi.org\/10.1002\/9780470122921.ch2","journal-title":"Adv Enzymol Relat Areas Mol Biol"},{"key":"7_CR92","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1128\/JVI.55.3.836-839.1985","volume":"55","author":"EA Emini","year":"1985","unstructured":"Emini EA, Hughes JV, Perlow DS, Boger J (1985) Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide. J Virol 55:836\u2013839. https:\/\/doi.org\/10.1128\/JVI.55.3.836-839.1985","journal-title":"J Virol"},{"key":"7_CR93","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/BF01195768","volume":"72","author":"PA Karplus","year":"1985","unstructured":"Karplus PA, Schulz GE (1985) Prediction of chain flexibility in proteins. Naturwissenschaften 72:212\u2013213. https:\/\/doi.org\/10.1007\/BF01195768","journal-title":"Naturwissenschaften"},{"key":"7_CR94","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/0014-5793(90)80535-q","volume":"276","author":"AS Kolaskar","year":"1990","unstructured":"Kolaskar AS, Tongaonkar PC (1990) A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett 276:172\u2013174. https:\/\/doi.org\/10.1016\/0014-5793(90)80535-q","journal-title":"FEBS Lett"},{"key":"7_CR95","doi-asserted-by":"publisher","first-page":"5425","DOI":"10.1021\/bi00367a013","volume":"25","author":"JM Parker","year":"1986","unstructured":"Parker JM, Guo D, Hodges RS (1986) New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites. Biochemistry 25:5425\u20135432. https:\/\/doi.org\/10.1021\/bi00367a013","journal-title":"Biochemistry"},{"key":"7_CR96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1002829","volume":"8","author":"JV Kringelum","year":"2012","unstructured":"Kringelum JV, Lundegaard C, Lund O, Nielsen M (2012) Reliable B cell epitope predictions: impacts of method development and improved benchmarking. PLoS Comput Biol 8:e1002829. https:\/\/doi.org\/10.1371\/journal.pcbi.1002829","journal-title":"PLoS Comput Biol"},{"key":"7_CR97","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1186\/1471-2105-9-514","volume":"9","author":"J Ponomarenko","year":"2008","unstructured":"Ponomarenko J, Bui H-H, Li W et al (2008) ElliPro: a new structure-based tool for the prediction of antibody epitopes. BMC Bioinformatics 9:514. https:\/\/doi.org\/10.1186\/1471-2105-9-514","journal-title":"BMC Bioinformatics"},{"key":"7_CR98","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1126\/science.1149751","volume":"318","author":"M Beyer","year":"2007","unstructured":"Beyer M, Nesterov A, Block I et al (2007) Combinatorial synthesis of peptide arrays onto a microchip. Science 318:1888. https:\/\/doi.org\/10.1126\/science.1149751","journal-title":"Science"},{"key":"7_CR99","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/msb.2011.75","volume":"7","author":"F Sievers","year":"2011","unstructured":"Sievers F, Wilm A, Dineen D et al (2011) Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol 7:539. https:\/\/doi.org\/10.1038\/msb.2011.75","journal-title":"Mol Syst Biol"},{"key":"7_CR100","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1471-2105-7-153","volume":"7","author":"H-H Bui","year":"2006","unstructured":"Bui H-H, Sidney J, Dinh K et al (2006) Predicting population coverage of T-cell epitope-based diagnostics and vaccines. BMC Bioinformatics 7:153. https:\/\/doi.org\/10.1186\/1471-2105-7-153","journal-title":"BMC Bioinformatics"},{"key":"7_CR101","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/1471-2105-8-361","volume":"8","author":"H-H Bui","year":"2007","unstructured":"Bui H-H, Sidney J, Li W et al (2007) Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines. BMC Bioinformatics 8:361. https:\/\/doi.org\/10.1186\/1471-2105-8-361","journal-title":"BMC Bioinformatics"},{"key":"7_CR102","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073957","volume":"8","author":"S Gupta","year":"2013","unstructured":"Gupta S, Kapoor P, Chaudhary K et al (2013) In silico approach for predicting toxicity of peptides and proteins. PLoS One 8:e73957. https:\/\/doi.org\/10.1371\/journal.pone.0073957","journal-title":"PLoS One"},{"key":"7_CR103","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/bioinformatics\/bti770","volume":"22","author":"K Arnold","year":"2006","unstructured":"Arnold K, Bordoli L, Kopp J, Schwede T (2006) The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22:195\u2013201. https:\/\/doi.org\/10.1093\/bioinformatics\/bti770","journal-title":"Bioinformatics"},{"key":"7_CR104","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13062-015-0103-4","volume":"10","author":"S Singh","year":"2015","unstructured":"Singh S, Singh H, Tuknait A et al (2015) PEPstrMOD: structure prediction of peptides containing natural, non-natural and modified residues. Biol Direct 10:73. https:\/\/doi.org\/10.1186\/s13062-015-0103-4","journal-title":"Biol Direct"},{"key":"7_CR105","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W et al (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30:2785\u20132791. https:\/\/doi.org\/10.1002\/jcc.21256","journal-title":"J Comput Chem"},{"key":"7_CR106","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455\u2013461. https:\/\/doi.org\/10.1002\/jcc.21334","journal-title":"J Comput Chem"},{"key":"7_CR107","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1\u20132","author":"MJ Abraham","year":"2015","unstructured":"Abraham MJ, Murtola T, Schulz R et al (2015) GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1\u20132:19\u201325. https:\/\/doi.org\/10.1016\/j.softx.2015.06.001","journal-title":"SoftwareX"},{"key":"7_CR108","doi-asserted-by":"publisher","first-page":"11225","DOI":"10.1021\/ja9621760","volume":"118","author":"WL Jorgensen","year":"1996","unstructured":"Jorgensen WL, Maxwell DS, Tirado-Rives J (1996) Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. J Am Chem Soc 118:11225\u201311236. https:\/\/doi.org\/10.1021\/ja9621760","journal-title":"J Am Chem Soc"},{"key":"7_CR109","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.21829","volume":"5","author":"ML Oldham","year":"2016","unstructured":"Oldham ML, Grigorieff N, Chen J (2016) Structure of the transporter associated with antigen processing trapped by herpes simplex virus. elife 5:e21829. https:\/\/doi.org\/10.7554\/eLife.21829","journal-title":"elife"},{"key":"7_CR110","doi-asserted-by":"publisher","first-page":"12478","DOI":"10.1038\/srep12478","volume":"5","author":"G Nagpal","year":"2015","unstructured":"Nagpal G, Gupta S, Chaudhary K et al (2015) VaccineDA: prediction, design and genome-wide screening of oligodeoxynucleotide-based vaccine adjuvants. Sci Rep 5:12478. https:\/\/doi.org\/10.1038\/srep12478","journal-title":"Sci Rep"},{"key":"7_CR111","doi-asserted-by":"publisher","first-page":"W202","DOI":"10.1093\/nar\/gkl343","volume":"34","author":"S Saha","year":"2006","unstructured":"Saha S, Raghava GPS (2006) AlgPred: prediction of allergenic proteins and mapping of IgE epitopes. Nucleic Acids Res 34:W202\u2013W209. https:\/\/doi.org\/10.1093\/nar\/gkl343","journal-title":"Nucleic Acids Res"},{"key":"7_CR112","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2105-8-4","volume":"8","author":"IA Doytchinova","year":"2007","unstructured":"Doytchinova IA, Flower DR (2007) VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics 8:4. https:\/\/doi.org\/10.1186\/1471-2105-8-4","journal-title":"BMC Bioinformatics"},{"key":"7_CR113","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1385\/1-59259-890-0:571","volume-title":"The proteomics protocols handbook","author":"E Gasteiger","year":"2005","unstructured":"Gasteiger E, Hoogland C, Gattiker A et al (2005) Protein identification and analysis tools on the ExPASy server. In: The proteomics protocols handbook. Humana Press, Totowa, NJ, pp 571\u2013607"},{"key":"7_CR114","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1038\/nprot.2012.085","volume":"7","author":"M K\u00e4llberg","year":"2012","unstructured":"K\u00e4llberg M, Wang H, Wang S et al (2012) Template-based protein structure modeling using the RaptorX web server. Nat Protoc 7:1511\u20131522. https:\/\/doi.org\/10.1038\/nprot.2012.085","journal-title":"Nat Protoc"},{"key":"7_CR115","doi-asserted-by":"publisher","first-page":"W294","DOI":"10.1093\/nar\/gks493","volume":"40","author":"J Ko","year":"2012","unstructured":"Ko J, Park H, Heo L, Seok C (2012) GalaxyWEB server for protein structure prediction and refinement. Nucleic Acids Res 40:W294\u2013W297. https:\/\/doi.org\/10.1093\/nar\/gks493","journal-title":"Nucleic Acids Res"},{"key":"7_CR116","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/prot.10286","volume":"50","author":"SC Lovell","year":"2003","unstructured":"Lovell SC, Davis IW, Arendall WB et al (2003) Structure validation by Calpha geometry: phi, psi and Cbeta deviation. Proteins 50:437\u2013450. https:\/\/doi.org\/10.1002\/prot.10286","journal-title":"Proteins"},{"key":"7_CR117","doi-asserted-by":"publisher","first-page":"W363","DOI":"10.1093\/nar\/gki481","volume":"33","author":"D Schneidman-Duhovny","year":"2005","unstructured":"Schneidman-Duhovny D, Inbar Y, Nussinov R, Wolfson HJ (2005) PatchDock and SymmDock: servers for rigid and symmetric docking. Nucleic Acids Res 33:W363\u2013W367. https:\/\/doi.org\/10.1093\/nar\/gki481","journal-title":"Nucleic Acids Res"},{"key":"7_CR118","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/jcc.23899","volume":"36","author":"E Krieger","year":"2015","unstructured":"Krieger E, Vriend G (2015) New ways to boost molecular dynamics simulations. J Comput Chem 36:996\u20131007. https:\/\/doi.org\/10.1002\/jcc.23899","journal-title":"J Comput Chem"},{"key":"7_CR119","doi-asserted-by":"publisher","first-page":"10913","DOI":"10.1063\/1.1324708","volume":"113","author":"A Toukmaji","year":"2000","unstructured":"Toukmaji A, Sagui C, Board J, Darden T (2000) Efficient particle-mesh Ewald based approach to fixed and induced dipolar interactions. J Chem Phys 113:10913\u201310927. https:\/\/doi.org\/10.1063\/1.1324708","journal-title":"J Chem Phys"},{"key":"7_CR120","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","volume":"25","author":"J Wang","year":"2004","unstructured":"Wang J, Wolf RM, Caldwell JW et al (2004) Development and testing of a general amber force field. J Comput Chem 25:1157\u20131174. https:\/\/doi.org\/10.1002\/jcc.20035","journal-title":"J Comput Chem"},{"key":"7_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2016.02.047","volume":"584","author":"S Morla","year":"2016","unstructured":"Morla S, Makhija A, Kumar S (2016) Synonymous codon usage pattern in glycoprotein gene of rabies virus. Gene 584:1\u20136. https:\/\/doi.org\/10.1016\/j.gene.2016.02.047","journal-title":"Gene"},{"key":"7_CR122","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1471-2105-11-61","volume":"11","author":"X Wu","year":"2010","unstructured":"Wu X, Wu S, Li D et al (2010) Computational identification of rare codons of Escherichia coli based on codon pairs preference. BMC Bioinformatics 11:61. https:\/\/doi.org\/10.1186\/1471-2105-11-61","journal-title":"BMC Bioinformatics"}],"container-title":["Methods in Molecular Biology","Vaccine Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-1884-4_7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T11:24:07Z","timestamp":1662117847000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-1884-4_7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,17]]},"ISBN":["9781071618837","9781071618844"],"references-count":122,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-1884-4_7","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2021,12,17]]},"assertion":[{"value":"17 December 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}